NephCure – Pilot Grant Program
NephCure’s Pilot Grant Program funds innovative glomerular disease research using CureGN and NEPTUNE resources to advance clinical and translational science.
Funder: NephCure Kidney International
Due Dates: January 15, 2027 (Letter of Intent) | March 19, 2027 (Ancillary Study Application) | July 16, 2027 (Full Application to NephCure)
Funding Amounts: Up to $250,000 direct costs per project (max $125,000/year for 2 years); no indirect costs; total program up to $500,000 for FY2028.
Summary: Supports investigator-initiated clinical and translational research in glomerular disease leveraging CureGN and/or NEPTUNE resources.
Key Information: Use of CureGN/NEPTUNE resources and consortia approval required before application.
Description
This program funds pilot projects that utilize the clinical data, biomaterials, and infrastructure of the CureGN and/or NEPTUNE consortia to advance research in glomerular disease. The initiative encourages multidisciplinary collaboration, data and resource sharing, and networking among both consortia participants and external investigators. Projects may include feasibility studies, development of clinical assays or protocols, or early-phase clinical trials, with an emphasis on generating preliminary data for future research. Both U.S. and international applicants are eligible, provided their work leverages CureGN/NEPTUNE resources and aligns with the consortia’s collaborative principles.
